Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.400 |
None |
1.000 |
16 |
|
1995 |
2009 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.360 |
None |
1.000 |
7 |
|
2002 |
2017 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.350 |
None |
1.000 |
6 |
|
2008 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.060 |
None |
1.000 |
6 |
|
2003 |
2019 |
Lung Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1486
|
39
|
0.340 |
None |
1.000 |
5 |
|
2001 |
2017 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.050 |
None |
1.000 |
5 |
|
2012 |
2019 |
Juvenile open angle
|
disease |
|
Disease or Syndrome
|
7
|
1
|
0.050 |
None |
1.000 |
5 |
|
2002 |
2018 |
Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2084
|
288
|
0.050 |
None |
1.000 |
5 |
|
2004 |
2015 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.040 |
None |
1.000 |
4 |
|
2013 |
2015 |
Irido-corneal dysgenesis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Congenital Abnormality
|
22
|
2
|
0.040 |
None |
1.000 |
4 |
|
2006 |
2018 |
Head and Neck Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
786
|
118
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2017 |
Malignant Head and Neck Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
767
|
118
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2017 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.340 |
None |
1.000 |
4 |
|
1998 |
2011 |
Hot flushes
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
32
|
1
|
0.030 |
None |
0.667 |
3 |
|
2005 |
2012 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.030 |
None |
1.000 |
3 |
|
2008 |
2020 |
Endometrial Neoplasms
|
group |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
261
|
32
|
0.030 |
None |
1.000 |
3 |
|
2003 |
2004 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.030 |
None |
1.000 |
3 |
|
2007 |
2009 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2016 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2015 |
estrogen receptor-negative breast cancer
|
disease |
|
Neoplastic Process
|
356
|
40
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2015 |
Slow acetylator due to N-acetyltransferase enzyme variant
|
disease |
|
Disease or Syndrome
|
20
|
8
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2010 |
Precursor Cell Lymphoblastic Leukemia Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
879
|
168
|
0.310 |
None |
1.000 |
2 |
|
2012 |
2013 |
Malignant transformation
|
phenotype |
|
Neoplastic Process
|
1027
|
20
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2003 |
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
|
0.300 |
None |
1.000 |
2 |
|
2005 |
2007 |
Congestive heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1760
|
165
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |